Patients with non-squamous non-small cell cancer may achieve similar outcomes with a subcutaneous formulation of the immunotherapy toripalimab as with IV administration.

SEOUL, South Korea--(BUSINESS WIRE)--A clinical study on safety found that multiple intravenous administrations of cultured human autologous adipose-derived stem cells which were cultured by Biostar ...

European regulators recommended a subcutaneous formulation for a key anti-CD38 therapy, offering clinicians and patients more flexible administration options for multiple myeloma.

RANIDO: A phase III clinical trial of racotumomab-alum or nimotuzumab versus docetaxel in advanced non-small cell lung cancer patients. Background: To date convincing clinical success with oncolytic ...

This episode, titled Optimizing Subcutaneous Therapies in NSCLC: Practical Integration, Patient Selection, and Workflow ...

Clinicians have a range of options for treating patients with disease states that require the use of immunoglobulin (Ig). Traditionally, intravenous immunoglobulin (IVIG) administration has provided ...

It Takes a Village! Navigating the Challenges and Opportunities in Immune-Related Adverse Event Management More broadly than this study, several contextual factors need to be considered before simply ...

A route of administration is a way that a drug can enter the body. There are many drug routes of administration, each suited to different situations. Each route has its benefits and potential risks.

Please provide your email address to receive an email when new articles are posted on . DENVER — Subcutaneous administration of ocrelizumab showed similar safety and efficacy profiles to IV ...

SIX young women who had the signs and symptoms of acute pyelonephritis associated with pregnancy died with liver disease. The illnesses were characterized by rapid progression and the combination of ...